SEARCH

SEARCH BY CITATION

References

  • Abad C, Martinez C, Juarranz MG, Arranz A, Receta J, Delgado M et al. (2003). Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterol 124: 961971.
  • Abrahams V, Visitin I, Aldo P, Guller S, Romero R, Mor G (2005). A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 176: 80968104.
  • Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2): S1209.
  • Aluvihare V, Kallikourdis M, Betz AG (2004). Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5: 266271.
  • Aplin JD, Straszewski-Chavez SL, Kalions B, Dunk C, Morrish D, Forbes K et al. (2006). Trophoblast differentiation: progenitor cells, fusion and migration. A workshop report. Placenta 27 (Suppl. A): S141.
  • Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, Cheng J et al. (2003). Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosci Res 15: 240247.
  • Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C (2008). VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29: 948956.
  • Arruvito L, Sanz M, Banham A, Fainboim L (2007). Expansion of CD4+CD25+FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 178: 25722578.
  • Auchincloss H Jr, Sachs DH (1998). Xenogeneic transplantation. Annu Rev Immunol 16: 433470.
  • Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsa LAS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC (2007). A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13: 14501457.
  • Bulletti C, Flamigni C, De Ziegler D (2005). Implantation markers and endometriosis. Reprod Biomed Online 11: 464468.
  • Bulmer JN, Sunderland C (1984). Immunological characterization of lymphoid cell populations in the early human placental bed. Immunology 52: 349357.
  • Chaouat G, Zourbas S, Ostoij S, Lappree-Delage G, Dubanchet S, Ledee N et al. (2002). A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 53: 241253.
  • Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J (2004). TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134: 93119.
  • Chaouat G, Dubanchet S, Ledée N (2007). Cytokines: important for implantation? J Assist Reprod Genet 24: 491505.
  • Chorny A, Gonzalez-Rey E, Fernandez Martin A, Ganea D, Delgado M (2006). Vasointestinal peptide induces regulatory dendritic cells that prevent acute graft-host disease while maintaining the graft-versus tumor response. Blood 107: 37873794.
  • Clark DA, Chaouat G, Gorczynsk G (2002). Thinking outside the box: mechanisms of environmental selective pressures on the outcome of the materno-fetal relationship. Am J Reprod Immunol 47: 275282.
  • Clark KE, Mills EG, Stys SJ, Seeds AE (1981). Effects of vasoactive polypeptides on the uterine vasculature. Am J Obstet and Gynecol 139: 182188.
  • Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999). Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 1: 17071716.
  • Delgado M, Abad C, Martinez C, Receta J, Gomariz RP (2001). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7: 563568.
  • Delgado M, Abad C, Martinez C, Juarranz MG (2002). Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 80: 1624.
  • Deon D, Ahmed S, Tai K, Scaletta N, Herrero C, Lee IH et al. (2001). Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J Immunol 1: 53955403.
  • Dimitriadis E, White CA, Jones RL, Salamonsen LA (2005). Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 11: 613630.
  • Ding AH, Nathan CF, Stuehr DJ (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 24042412.
  • Domínguez F, Martínez S, Quiñonero A, Loro F, Horcajadas JA, Pellicer A et al. (2008). CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines. Mol Hum Reprod 14: 423430.
  • Ekström J, Mansson B, Tobin G (1983). Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity. Acta Physiol Scand 199: 169175.
  • Fest S, Aldo P, Abrahams VM, Alvero I, Chen R, Chavez SL et al. (2000). Trophoblast-macrophage Interactions: a Regulatory network for the protection of pregnancy. Am J Reprod Immunol 5: 5566.
  • Gomariz RP, Martinez C, Abadd C, Leceta J, Delgado M (2001). Immunology of VIP: a review and therapeutical perspectives. Curr Pharm Des 7: 89111.
  • Gonzalez-Rey E, Anderson P, Delgado M (2007). Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. Ann Rheum Dis 66: 7076.
  • Gressens P, Paindaveine B, Hill JM, Evrard P, Brenneman DE (1998). Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur J Neurosci 10: 17341742.
  • Gutiérrez-Cañas I, Rodríguez-Henche N, Bolaños O, Carmena MJ, Prieto JC, Juarranz MG (2003). VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br J Pharmacol 139: 10501058.
  • Gutiérrez-Cañas I, Juarranz Y, Santiago B, Arranz A, Martinez C, Galindo M et al. (2006). VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology 45: 527532.
  • Henson PM, Bratton DL, Fadok VA (2001). The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2: 627633.
  • Inoue Y, Kaku K, Kaneko T, Yanahara N, Kanno T (1985). Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′–5′-monophosphate. Endocrinology 116: 686692.
  • Jovanovic A, Jovanovic S, Tulic I, Grbovic L (1998). Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Mol Hum Reprod 4: 7176.
  • Kawano Y, Fukuda J, Nasu K, Matsumoto H, Narahara H, Miyakawa I (2004). Synergistic effect of interleukin (IL)-1alpha and ceramide analogue on the production of IL-6, IL-8, and macrophage colony-stimulating factor by endometrial stromal cells. Fertil Steril 3: 10431047.
  • Killedar SJ, Eckenrode SE, McIndoe RA, She JX, Nguyen CQ, Peck AB et al. (2006). Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 86: 12431260.
  • Larocca L, Calafat M, Roca V, Franchi AM, Leirós CP (2007). VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages. Int Immunopharmacol 10: 13431349.
  • Larocca L, Ramhorst R, Roca V, Calafat M, Aisemberg J, Franchi A, Pérez-Leirós (2008). Neuroimmune-endocrine interactions during early pregnancy in an autoimmune context: focus on macrophage activation. Neuroimmunemodulation 15: 8490.
  • Mauri C, Williams RO, Walmsley M, Feldmann M (1996). Relationship between Th1/Th2 cytokine patterns ans arthritogenic response in collagen-induced arthritis. Eur J Immunol 26: 15111520.
  • Paria B, Reese J, Das S, Dey S (2002). Deciphering the cross talk of implantation: advances and challenges. Science 296: 21852188.
  • Piccinni MP (2007). Role of T-cell cytokines in decidua and in cumulus oophorus during pregnancy. Gynecol Obstet Invest 64: 144148.
  • Pregi N, Vittori D, Pérez G, Pérez Leirós C, Nesse A (2006). Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells. Biochim Biophys Acta 1763: 238246.
  • Rosignoli F, Torraoba M, Juarranz J, Garcia-Gomez M, Martinez C, Gomariz RP et al. (2006). VIP and tolerance induction in autoimmunity. Ann N Y Acad Sci 1070: 525530.
  • Rugeles MT, Shearer GM (2004). Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol 25: 348352.
  • Saito S (2000). Cytokine network at feto-maternal interface. J Reprod Immunol 47: 87103.
  • Sherman LA, Chattopadhyay S (1993). The molecular basis of allorecognition. Annu Rev Immunol 11: 385402.
  • Song H, Lim H (2006). Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation. Reproduction 131: 341349.
  • Spong C, Lee S, Mcune S, Gibney G, Abebe D, Alvero R et al. (1999). Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 140: 917924.
  • Sreedharan SP, Huang JX, Cheung MC, Goetzl EJ (1995). Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci USA 92: 29392943.
  • Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA (2007). Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 58: 238254.
  • Thellin O, Coumans B, Zorzi W, Igout A, Heinen A (2000). Tolerance to the foeto-placental ‘graft’: ten ways to support a child for nine months. Curr Opin Immunol 12: 731737.
  • Wheeler S, Eardley JE, McNulty KF, Sutcliffe CP, Morrison JD (1997). An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Exp Physiol 82: 729747.